Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Stuart J. Wong MD

Stuart J. Wong MD

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology
Program: Hematology

Member of the Cancer Center


Publications

  • Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab. (Taylor RJ, Saloura V, Jain A, Goloubeva O, Wong S, Kronsberg S, Nagilla M, Silpino L, de Souza J, Seiwert T, Vokes E, Villaflor V, Cohen EE) Cancer Immunol Res 2015 May;3(5):567-74 PMID: 25769300 03/15/2015
  • Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 1;91(1):116-23 PMID: 25446610 PMCID: PMC4385459 12/03/2014
  • EGFRvIII expression in squamous cell carcinoma of the skin. (Dziunycz PJ, Lazarova Z, Duncan N, Wong S, Neuburg M, Hofbauer GF, Olasz EB) JAMA Dermatol 2013 Oct;149(10):1240-2 PMID: 23986462 08/30/2013
  • A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. (Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EE, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E) Oral Oncol 2013 Sep;49(9):970-6 PMID: 23845699 PMCID: PMC4456032 07/13/2013
  • Neoadjuvant versus induction chemotherapy: more than semantics. (Devisetty K, Wong SJ) J Clin Oncol 2013 Aug 10;31(23):2971-2 PMID: 23733777 06/05/2013
  • Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. (Johnson A, Tarima S, Wong S, Friedland DR, Runge CL) JAMA Otolaryngol Head Neck Surg 2013 Mar;139(3):256-64 PMID: 23429908 02/23/2013
  • Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent. (Randhawa J, Wong S, Atallah E, Olasz E) Int J Dermatol 2014 Jan;53(1):e13-4 PMID: 22998756 09/25/2012
  • Retreatment of recurrent head and neck cancer in a previously irradiated field. (Wong SJ, Bourhis J, Langer CJ) Semin Radiat Oncol 2012 Jul;22(3):214-9 PMID: 22687946 06/13/2012
  • Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN). (Ang KK, Chen A, Curran WJ Jr, Garden AS, Harari PM, Murphy BA, Wong SJ, Bellm LA, Schwartz M, Newman J, Adkins D, Hayes DN, Parvathaneni U, Brachman D, Ghabach B, Schneider CJ, Greenberg M, AnnĂ© PR) Cancer 2012 Dec 1;118(23):5783-92 PMID: 22569917 05/10/2012
  • A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. (de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, Vokes EE, Cohen EE) Clin Cancer Res 2012 Apr 15;18(8):2336-43 PMID: 22371453 PMCID: PMC4467891 03/01/2012
  • Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. (Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S) Int J Radiat Oncol Biol Phys 2012 Jun 1;83(2):690-5 PMID: 22112556 11/25/2011
  • Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 PMID: 21775070 PMCID: PMC3208721 07/22/2011
  • How does TPF improve survival over PF? (Devisetty K, Wong SJ, Mell LK) Lancet Oncol 2011 May;12(5):419-20; author reply 421-2 PMID: 21536218 05/04/2011
  • Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States. (Wong SJ, Harari PM, Garden AS, Schwartz M, Bellm L, Chen A, Curran WJ, Murphy BA, Ang KK) Cancer 2011 Apr 15;117(8):1679-86 PMID: 21472715 04/08/2011
  • Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. (Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 1;81(5):e825-32 PMID: 21300450 02/09/2011
  • Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. (Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):279-86 PMID: 21135267 PMCID: PMC3056463 12/08/2010
  • Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8 PMID: 21135270 PMCID: PMC3056462 12/08/2010
  • Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. (Murphy BA, Chen A, Curran WJ Jr, Garden AS, Harari PM, Wong SJ, Ang KK) Support Care Cancer 2009 Nov;17(11):1393-401 PMID: 19263090 03/06/2009
  • Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. (Vernon MR, Maheshwari M, Schultz CJ, Michel MA, Wong SJ, Campbell BH, Massey BL, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2008 Mar 1;70(3):678-84 PMID: 18262086 02/12/2008
  • Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? (Wong SJ, Machtay M, Li Y) J Clin Oncol 2006 Jun 10;24(17):2653-8 PMID: 16763279 06/10/2006
  • Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. (Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF) Int J Radiat Oncol Biol Phys 2006 May 1;65(1):143-51 PMID: 16618577 04/19/2006
  • Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase. (Green DA, Antholine WE, Wong SJ, Richardson DR, Chitambar CR) Clin Cancer Res 2001 Nov;7(11):3574-9 PMID: 11705879 11/14/2001
  • Increased sensitivity of hydroxyurea-resistant leukemic cells to gemcitabine. (Wong SJ, Myette MS, Wereley JP, Chitambar CR) Clin Cancer Res 1999 Feb;5(2):439-43 PMID: 10037195 02/26/1999
  • Last update: 04/22/2014